124 related articles for article (PubMed ID: 26284135)
1. Vasculature Disruption Enhances Bacterial Targeting of Autochthonous Tumors.
Drees JJ; Mertensotto MJ; Augustin LB; Schottel JL; Saltzman DA
J Cancer; 2015; 6(9):843-8. PubMed ID: 26284135
[TBL] [Abstract][Full Text] [Related]
2.
Augustin LB; Milbauer L; Hastings SE; Leonard AS; Saltzman DA; Schottel JL
J Drug Target; 2021 Mar; 29(3):294-299. PubMed ID: 32886538
[TBL] [Abstract][Full Text] [Related]
3. Attenuated Salmonella enterica Typhimurium reduces tumor burden in an autochthonous breast cancer model.
Drees J; Mertensotto M; Liu G; Panyam J; Leonard A; Augustin L; Schottel J; Saltzman D
Anticancer Res; 2015 Feb; 35(2):843-9. PubMed ID: 25667465
[TBL] [Abstract][Full Text] [Related]
4. Low dose chemotherapy combined with attenuated Salmonella decreases tumor burden and is less toxic than high dose chemotherapy in an autochthonous murine model of breast cancer.
Saltzman D; Augustin L; Leonard A; Mertensotto M; Schottel J
Surgery; 2018 Mar; 163(3):509-514. PubMed ID: 29229318
[TBL] [Abstract][Full Text] [Related]
5. Regulated antigen expression in live recombinant Salmonella enterica serovar Typhimurium strongly affects colonization capabilities and specific CD4(+)-T-cell responses.
Bumann D
Infect Immun; 2001 Dec; 69(12):7493-500. PubMed ID: 11705925
[TBL] [Abstract][Full Text] [Related]
6. H2-M3 major histocompatibility complex class Ib-restricted CD8 T cells induced by Salmonella enterica serovar Typhimurium infection recognize proteins released by Salmonella serovar Typhimurium.
Ugrinovic S; Brooks CG; Robson J; Blacklaws BA; Hormaeche CE; Robinson JH
Infect Immun; 2005 Dec; 73(12):8002-8. PubMed ID: 16299293
[TBL] [Abstract][Full Text] [Related]
7. Tumor invasion of Salmonella enterica serovar Typhimurium is accompanied by strong hemorrhage promoted by TNF-alpha.
Leschner S; Westphal K; Dietrich N; Viegas N; Jablonska J; Lyszkiewicz M; Lienenklaus S; Falk W; Gekara N; Loessner H; Weiss S
PLoS One; 2009 Aug; 4(8):e6692. PubMed ID: 19693266
[TBL] [Abstract][Full Text] [Related]
8. Sparse initial entrapment of systemically injected Salmonella typhimurium leads to heterogeneous accumulation within tumors.
Forbes NS; Munn LL; Fukumura D; Jain RK
Cancer Res; 2003 Sep; 63(17):5188-93. PubMed ID: 14500342
[TBL] [Abstract][Full Text] [Related]
9. In tumors Salmonella migrate away from vasculature toward the transition zone and induce apoptosis.
Ganai S; Arenas RB; Sauer JP; Bentley B; Forbes NS
Cancer Gene Ther; 2011 Jul; 18(7):457-66. PubMed ID: 21436868
[TBL] [Abstract][Full Text] [Related]
10. Chlortetracycline Enhances Tonsil Colonization and Fecal Shedding of Multidrug-Resistant
Holman DB; Bearson BL; Allen HK; Shippy DC; Loving CL; Kerr BJ; Bearson SMD; Brunelle BW
Appl Environ Microbiol; 2019 Feb; 85(4):. PubMed ID: 30530706
[No Abstract] [Full Text] [Related]
11. Synergistic antitumoral effects of human telomerase reverse transcriptase-mediated dual-apoptosis-related gene vector delivered by orally attenuated Salmonella enterica Serovar Typhimurium in murine tumor models.
Fu W; Chu L; Han X; Liu X; Ren D
J Gene Med; 2008 Jun; 10(6):690-701. PubMed ID: 18338832
[TBL] [Abstract][Full Text] [Related]
12. Refined live attenuated Salmonella enterica serovar Typhimurium and Enteritidis vaccines mediate homologous and heterologous serogroup protection in mice.
Tennant SM; Schmidlein P; Simon R; Pasetti MF; Galen JE; Levine MM
Infect Immun; 2015 Dec; 83(12):4504-12. PubMed ID: 26351285
[TBL] [Abstract][Full Text] [Related]
13. Influence of infection route and virulence factors on colonization of solid tumors by Salmonella enterica serovar Typhimurium.
Crull K; Bumann D; Weiss S
FEMS Immunol Med Microbiol; 2011 Jun; 62(1):75-83. PubMed ID: 21314734
[TBL] [Abstract][Full Text] [Related]
14. Anti-flagellin antibody responses elicited in mice orally immunized with attenuated Salmonella enterica serovar Typhimurium vaccine strains.
Massis LM; Braga CJ; Sbrogio-Almeida ME; Lauand C; Newton SM; Klebba PE; Ferreira LC
Mem Inst Oswaldo Cruz; 2008 Sep; 103(6):606-10. PubMed ID: 18949334
[TBL] [Abstract][Full Text] [Related]
15. Characterization of a highly attenuated Salmonella enterica serovar Typhimurium mutant strain.
Tang IK; Ji DD; Chou CF; Lin HC; Liao CL; Sytwu HK; Wang JJ; Liu YT
J Microbiol Immunol Infect; 2002 Dec; 35(4):229-35. PubMed ID: 12542248
[TBL] [Abstract][Full Text] [Related]
16. Oral vaccination of BALB/c mice with Salmonella enterica serovar Typhimurium expressing Pseudomonas aeruginosa O antigen promotes increased survival in an acute fatal pneumonia model.
DiGiandomenico A; Rao J; Goldberg JB
Infect Immun; 2004 Dec; 72(12):7012-21. PubMed ID: 15557624
[TBL] [Abstract][Full Text] [Related]
17. Optimizing Salmonella enterica serovar Typhimurium for bacteria-mediated tumor therapy.
Felgner S; Kocijancic D; Frahm M; Curtiss R; Erhardt M; Weiss S
Gut Microbes; 2016; 7(2):171-7. PubMed ID: 26939530
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of Salmonella enterica serovar Typhimurium and Choleraesuis slyA mutant strains for use in live attenuated oral vaccines.
Haneda T; Okada N; Kikuchi Y; Takagi M; Kurotaki T; Miki T; Arai S; Danbara H
Comp Immunol Microbiol Infect Dis; 2011 Sep; 34(5):399-409. PubMed ID: 21840053
[TBL] [Abstract][Full Text] [Related]
19. Genetic detoxification of an aroA Salmonella enterica serovar Typhimurium vaccine strain does not compromise protection against virulent Salmonella and enhances the immune responses towards a protective malarial antigen.
McKelvie ND; Khan SA; Karavolos MH; Bulmer DM; Lee JJ; DeMarco R; Maskell DJ; Zavala F; Hormaeche CE; Khan CM
FEMS Immunol Med Microbiol; 2008 Mar; 52(2):237-46. PubMed ID: 18177343
[TBL] [Abstract][Full Text] [Related]
20. Use of a recombinant Salmonella enterica serovar Typhimurium strain expressing C-Raf for protection against C-Raf induced lung adenoma in mice.
Gentschev I; Fensterle J; Schmidt A; Potapenko T; Troppmair J; Goebel W; Rapp UR
BMC Cancer; 2005 Feb; 5():15. PubMed ID: 15703070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
